Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020.

Mufaddal MahesriAmeet SarpatwariKrista F HuybrechtsJoyce LiiSu Been LeeGita A ToyserkaniCynthia LaCivitaEsther H ZhouGerald J Dal PanAaron S KesselheimKatsiaryna Bykov

Published in: Drug safety (2024)

Although most patients who initiated lenalidomide, pomalidomide, and thalidomide were not of child-bearing potential, further investigation into actual non-adherence to pregnancy testing is needed.

Keyphrases

multiple myeloma
preterm birth
pregnancy outcomes
climate change
newly diagnosed
mental health
low dose
human health
pregnant women
metabolic syndrome
adipose tissue
high dose